Abstract
The effect of prostate-specific antigen (PSA) screening on prostate cancer mortality remains debated, despite evidence from randomized trials. We investigated the association between prostate cancer incidence, reflecting uptake of PSA testing, and prostate cancer mortality.
Original language | English |
---|---|
Pages (from-to) | dju007 |
Journal | Journal of the National Cancer Institute |
Volume | 106 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2014 |
Subject classification (UKÄ)
- Cancer and Oncology